Company news

Allergy Therapeutics plc news in 2016

Allergy Therapeutics plc's news releases, calls and decks from 2016, newest first.

View company

Grant of Awards

December 30, 2016

EU Patent Office grants patent for MCT

November 2, 2016

Issue of equity in respect of exercise of options

October 27, 2016

New data from novel adjuvant system

October 10, 2016

Hardman Research: Performance drives market share

September 26, 2016

Allergy Therapeutics Preliminary Results

September 26, 2016

Notice of Preliminary Results

September 5, 2016

Results of mite immunotherapy Acarovac PlusT

July 8, 2016

Findings from mEEC dose range finding study G204

June 27, 2016

Allergy hosts Satellite Symposium at EAACI

June 13, 2016

Appointment of Finance Director

June 10, 2016

Positive Phase II Data

May 9, 2016

Issue of equity in respect of options exercise

March 23, 2016

Grant of Options under Long Term Incentive Plan

March 11, 2016

Interim Results for the six months ended 31/12/15

March 8, 2016

Hardman & Co Research Report: Development Progress

February 24, 2016

Patient enrolment completed in US Phase IIb study

February 18, 2016

Decks in 2016